Biontech SE

BNTX · NASDAQ

$91.17+$1.96 (+2.20%)TodayMarket closed ·
Prev close $89.21

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. The firm focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The firm is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. The company also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Employees
7,807
Headquarters
Mainz, Rheinland-Pfalz
Listed
Oct 10, 2019
Sector
Health Care
Industry
Biotechnology

Leadership

Biontech SE executives
NameTitleSince
Helmut Jeggle—2008
Prof. Ugur Sahin——
Ulrich Wandschneider—2018
Ramon Zapata Gomez——
Sierk Poetting——
Kylie Jimenez——
Annemarie Hanekamp——
James Ryan——
Oezlem Tuereci——
Prof. Anja Morawietz——
Michael Motschmann——
Prof. Rudolf Staudigl——
Baroness Blackwood——
Michael Horowicz—2025

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Biontech SE suppliers and customers
CompanyRelationshipCorrelation
Maravai Lifesciences A MRVISupplier0.82
Pfizer Ltd /IndiaSupplier and customer0.82
Genmab GMAB.COSupplier and customer0.78
Immunicum IMMU.STSupplier and customer0.78
Siegfried Holding SFZN.SWSupplier0.75
Takara BioSupplier and customer0.74
Scancell Holdings SCLP.LSupplier and customer0.71
PCI Biotech Holding PCIB.OLSupplier and customer0.70
Roivant Sciences ROIVSupplier and customer0.70
Shanghai Fosun Pharm HSupplier and customer0.66

Similar companies

Companies in the same industry as Biontech SE

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.